Institute 1 (ticket)
Advanced Clinical Psychopharmacology in the DSM-5 Era

With the tremendous expansion of the scientific evidence base, practicing clinicians require ongoing education on optimal approaches to clinical assessment and medical decision making for medication management. This Institute provides practical information for the practicing clinician. Presenters review current psychotropic medications and strategies for their use in pediatric groups, with particular focus on understanding the major medication classes, choosing individual medications within each class, and recognizing appropriate approaches to safety monitoring. Participants learn to identify changes in diagnostic classification based on implementation of DSM-5, name specific medication in each major class of psychotropic drugs, and describe features of a safety management plan.
Tuesday, October 22, 2013: 8:00 AM-5:00 PM
8:00 AM  
Welcome and Introduction
8:15 AM  
Medication Treatments of Anxiety Disorders in Children and Adolescents
John T. Walkup, MD Weill Cornell Medical College, New York, NY
9:00 AM  
Management of Treatment Resistant Depression in Children and Adolescents
Karen Dineen Wagner, MD, PhD University of Texas Medical Branch, Galveston, TX
9:45 AM  
Panel Discussion I
10:10 AM  
10:30 AM  
Autism Spectrum Disorders
Bryan H. King, MD Seattle Children's Hospital and University of Washington, Seattle, WA
11:15 AM  
Schizophrenia and Psychotic Disorders
Robert L. Findling, MD, MBA The Johns Hopkins University/Kennedy Kreiger Institute, Baltimore, MD
12:00 PM  
Panel Discussion II
12:25 PM  
Lunch (on your own)
1:30 PM  
DSM-5 and Disruptive Mood Dysregulation Disorder
Gabrielle A. Carlson, MD Stony Brook University, Stony Brook, NY
2:15 PM  
Office-Based Management of ADHD
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
3:00 PM  
Panel Discussion III
3:25 PM  
3:45 PM  
Medications for Sleep in Children and Adolescents
Judith Owens, MD, MPH George Washington University School of Medicine and Health Sciences, Washington, DC
4:30 PM  
Panel Discussion IV
4:45 PM  
Concluding Remarks

See more of: Institute
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.